A Phase 1/2 Open-Label, Multicenter, Dose Escalation and Expansion Study of AVB-001, an Intraperitoneally Administered, Cell-Generated, Human IL-2 Immunotherapy in Patients With Platinum-Resistant, High-Grade, Serous Adenocarcinoma of the Ovary, Primary Peritoneum, or Fallopian Tube

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT05538624

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:39:48.618799+00:00

Published At

2024-04-24T00:00:00+00:00

Record Updated At

2024-04-24

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Neoplasm, Ovarian", "Fallopian Tube Cancer", "Primary Peritoneal Cavity Cancer", "Adenocarcinoma Ovary", "Serous Adenocarcinoma of Ovary", "Serous Adenocarcinoma of Primary Peritoneum", "Primary Peritoneal Carcinoma", "High Grade Serous Adenocarcinoma"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2024-04-24"

protocolSection.identificationModule.nctId

"NCT05538624"

protocolSection.identificationModule.officialTitle

"A Phase 1/2 Open-Label, Multicenter, Dose Escalation and Expansion Study of AVB-001, an Intraperitoneally Administered, Cell-Generated, Human IL-2 Immunotherapy in Patients With Platinum-Resistant, High-Grade, Serous Adenocarcinoma of the Ovary, Primary Peritoneum, or Fallopian Tube"

protocolSection.statusModule.overallStatus

"TERMINATED"

protocolSection.designModule.phases

["PHASE1", "PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Neoplasm, Ovarian (protocolSection.conditionsModule.conditions)
• Fallopian Tube Cancer (protocolSection.conditionsModule.conditions)
• Primary Peritoneal Cavity Cancer (protocolSection.conditionsModule.conditions)
• Adenocarcinoma Ovary (protocolSection.conditionsModule.conditions)
• Serous Adenocarcinoma of Ovary (protocolSection.conditionsModule.conditions)
• Serous Adenocarcinoma of Primary Peritoneum (protocolSection.conditionsModule.conditions)
• Primary Peritoneal Carcinoma (protocolSection.conditionsModule.conditions)
• High Grade Serous Adenocarcinoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.